Our Company

PharmaReview Corporation  was founded with a vision to develop the next generation of  therapeutics based on recombinant human lactoferrin (rhLTF). Dr. Kruzel,  the company’s founder, has been researching the immuno-regulatory  functions of lactoferrin (LTF) for over 20 years; he is a co-inventor on  eight patents and over 50 peer-reviewed articles regarding structure  and function of LTF. Dr. Kruzel is a Faculty within the Department of  Integrative Biology and Pharmacology at UTHealth, McGovern Medical  School at Houston, TX.

Our mission: A clear path to clinical utility of novel biotherapeutics.